Doctor profile · Federal record
Dr. Chelsea Flowe, NP
Nurse Practitioner · Fresno, CA
- NPI 1871682815
- Accepts Medicare
- MIPS 80.2 / 100 · 2023
- 21 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
550 E Herndon Ave, #101
Fresno, CA 937202992
(559) 261-0990
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- December 15, 2010
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- California #NPF15734
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1871682815. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,542
Distinct HCPCS
10
Medicare allowed
$293,805
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 8,100 | 103 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 796 | 387 | $111 | |
82962 |
Blood glucose (sugar) test performed by hand-held instrument | 336 | 194 | $3 | |
96372 |
Injection of drug or substance under skin or into muscle | 141 | 98 | $12 | |
J3489 |
Injection, zoledronic acid, 1 mg | 60 | 12 | $8 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 49 | 46 | $155 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 20 | 19 | $79 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 16 | 16 | $144 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 12 | 12 | $58 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 12 | 12 | $97 |
In context: peer comparison
Among 29 peers in Fresno Nurse Practitioner, average services per provider: 142. This provider delivers 67× the peer median.Open Payments
Industry payments received
All-time total
$1,849
Transactions
83
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lilly USA, LLC | 26 | $487.53 | |
| Novo Nordisk INC | 12 | $257.03 | |
| Amgen INC. | 10 | $229.60 | |
| Tandem Diabetes Care, INC. | 4 | $112.52 | |
| Dexcom, INC. | 5 | $98.14 | |
| Abbvie INC. | 4 | $97.94 | |
| Abbott Laboratories | 4 | $79.33 | |
| Radius Health, INC. | 3 | $67.98 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 3 | $67.32 | |
| Kyowa Kirin, INC. | 3 | $62.87 | |
| Medtronic, INC. | 2 | $62.31 | |
| Mannkind Corporation | 1 | $50.80 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $48.74 | |
| Xeris Pharmaceuticals, INC. | 3 | $45.28 | |
| Recordati_Rare_Diseases_INC. | 1 | $25.67 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,797
Patients
549
Total drug cost
$1,178,677
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 233 | 64 | $443,819 |
| Metformin Hcl ER (Metformin Hcl) | Brand | 183 | 61 | $4,131 |
| Rosuvastatin Calcium | Generic | 153 | 43 | $3,394 |
| Synthroid (Levothyroxine Sodium) | Brand | 123 | 32 | $13,148 |
| Trulicity (Dulaglutide) | Brand | 122 | 24 | $183,049 |
| Metformin Hcl | Generic | 118 | 36 | $1,495 |
| Levothyroxine Sodium | Generic | 113 | 41 | $52,612 |
| Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) | Brand | 111 | 34 | $96,689 |
| Pioglitazone Hcl | Generic | 111 | 38 | $2,832 |
| Atorvastatin Calcium | Generic | 107 | 34 | $2,224 |
Frequently asked questions
What is Dr. Chelsea Flowe's medical specialty?
Dr. Chelsea Flowe practices Nurse Practitioner in Fresno, CA.
Where does Dr. Chelsea Flowe practice?
Dr. Chelsea Flowe practices at 550 E Herndon Ave, Fresno, CA 937202992. Office phone: 5592610990.
What is Dr. Chelsea Flowe's NPI?
Dr. Chelsea Flowe's National Provider Identifier (NPI) is 1871682815, issued by NPPES.
Does Dr. Chelsea Flowe accept Medicare assignment?
Yes. Dr. Chelsea Flowe accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Chelsea Flowe commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Blood glucose (sugar) test performed by hand-held instrument (HCPCS 82962). Source: CMS Medicare Physician & Other Practitioners file.